&w=3840&q=100)
Influx Healthtech lists at 38% premium on NSE SME, beats GMP estimates
Influx Healthtech IPO listing today: Shares of healthcare-focused contract manufacturer Influx Healthtech made a robust market debut on Wednesday, June 25, 2025, listing at ₹132.5 on the NSE SME platform, a premium of 38 per cent from its issue price of ₹96 per share. After the listing, shares of Influx Healthtech were trading at 127.5, down 3.77 per cent from the opening price.
Influx Healthtech debut was significantly above the grey market expectations. Ahead of listing, the unlisted shares of Influx Healthtech were trading ₹116, reflecting a premium of ₹20 or 20.8 per cent against the issue price.
Influx Healthtech IPO subscription
The company offered shares in the price band of ₹91 to ₹96 with a lot size of 1,200 shares. It received bids for 81,75,38,400 shares against the 40,58,400 shares offered, resulting in an oversubscription of 201 times by the end of the subscription period, showed NSE data.
Influx Healthtech IPO details
Influx Healthtech IPO was combination of fresh issue of 5 million equity shares to raise ₹48 crore and offer for sale (OFS) of 1.1 million equity shares aggregating to ₹10.56 crore.
Influx Healthtech IPO was available for subscription from Wednesday, June 18, 2025, till Friday, June 20, 2025. The basis of allotment of shares was finalised on Monday, June 23, 2025.
Maashitla Securities was the registrar of the issue. Rarever Financial Advisors was the book-running lead manager of the Influx Healthtech IPO.
According to the red herring prospectus (RHP), the company plans to use the net fresh issue proceeds to set up a manufacturing facility for Nutraceutical Division, another manufacturing facility for Veterinary Food Division, and purchase of machinery for homecase and cosmetic division. The remaining funds will be used for general corporate purposes.
About Influx Healthtech
Incorporated in 2020, Influx Healthtech is a Mumbai-based, healthcare-focused company specialising in contract manufacturing. The company operates three manufacturing units in Thane, Maharashtra. The company's expertise spans the production of Dietary and Nutritional Supplements, Cosmetics, Ayurvedic/Herbal Products, Veterinary Feed Supplements, Homecare Products, Active Pharmaceutical Ingredients (API), and finished dosage forms, including tablets, capsules and injectables.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
21 minutes ago
- Time of India
US Steel names Kevin Lewis as CFO, Infra News, ET Infra
Advt US Steel said on Tuesday Kevin Lewis would replace CFO Jessica Graziano effective immediately, days after the steelmaker closed its sale to Japan's Nippon who has spent nearly three years at the company, would stay on as a special advisor until July 18 to aid with the transition, US Steel who joined the Pittsburgh-based steelmaker 17 years ago, has held key positions across finance, strategy and investor company also appointed Scot Duncan as senior vice president, general counsel and secretary, effective move comes after Nippon Steel completed its $14.9-billion acquisition of US Steel last week, marking the end to an 18-month regulatory battle.
Business Standard
21 minutes ago
- Business Standard
Radico Khaitan Ltd gains for third straight session
Radico Khaitan Ltd is quoting at Rs 2718.7, up 1.32% on the day as on 12:49 IST on the NSE. The stock is up 51.04% in last one year as compared to a 5.55% slide in NIFTY and a 3.13% slide in the Nifty FMCG index. Radico Khaitan Ltd gained for a third straight session today. The stock is quoting at Rs 2718.7, up 1.32% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.59% on the day, quoting at 25192.55. The Sensex is at 82591.67, up 0.65%. Radico Khaitan Ltd has gained around 11.42% in last one month. Meanwhile, Nifty FMCG index of which Radico Khaitan Ltd is a constituent, has gained around 4.12% in last one month and is currently quoting at 54346.3, up 0.65% on the day. The volume in the stock stood at 1.49 lakh shares today, compared to the daily average of 3.21 lakh shares in last one month. The PE of the stock is 104.04 based on TTM earnings ending March 25.
Mint
29 minutes ago
- Mint
Pushpa Jewellers IPO: Here's date, price band, GMP and other details
B2B jewellery maker Pushpa Jewellers initial public offering (IPO) is all set to open for subscription on June 30. The SME segment IPO will remain open for bidding till July 2. The jewellery maker company has set price band at ₹ 143 - ₹ 147, with a face value of ₹ 10. The IPO is a book-built issue totaling ₹ 98.65 crore. It comprises a fresh issue of 53.70 lakh shares worth ₹ 78.94 crore and an offer for sale of 13.41 lakh shares amounting to ₹ 19.71 crore. The minimum lot size for an application is 1000. The minimum amount of investment required by retail investors is ₹ 1,43,000. The allotment for the Pushpa Jewellers IPO is likely to be finalized on Thursday, July 3. The IPO is set to be listed on the NSE SME platform, with a tentative listing date scheduled for Monday, July 7. The net proceeds from the IPO will be utilized to finance the establishment of the proposed new showroom, including the capital expenditure cost and inventory cost for the showroom, funding working capital requirements and general corporate purpose. The anchor portion will open on June 27, 2025 and issue will close on July 02. Affinity Global Capital Market Private Limited is the book-running lead manager of the Pushpa Jewellers IPO, while Cameo Corporate Services Limited is the registrar for the issue. The market maker for Pushpa Jewellers IPO is Sunflower Broking Private Limited. 'Our journey began with a clear vision to craft timeless jewellery that blends tradition with elegance. Over the years, we have not only built a strong presence across India but have also taken our designs to international markets through our growing export business. Today, we are proud to be recognised for our design excellence, quality craftsmanship, and customer trust," said Anupam Tibrewal, Managing Director of Pushpa Jewellers. Tibrewal further added, " The proceeds will support the establishment of a new showroom, enabling us to strengthen our retail footprint and offer an enriched customer experience. This expansion is part of our broader plan to scale operations, explore untapped markets both domestic and overseas, and further solidify our position in the jewellery industry." The shares of Pushpa Jewellers is currently not trading in the grey market. 'Grey market premium' indicates investors' readiness to pay more than the issue price. Pushpa Jewellers Limited is a Wholesaler jewellery maker in the B2B segment with a presence across India. The Company is one of the leading jewellery manufacturers specializing in both traditional and modern gold jewellery. It offers a wide range of gold jewellery, incorporating fine stones like Emerald, Jade, Pearl, and Meena. In FY24, the company reported a revenue of ₹ 25,534.28 lakhs, an operating EBITDA of ₹ 1,987.50 lakhs, and a profit after tax (PAT) of ₹ 1,357.70 lakhs. In FY25, the company's performance improved, with revenue rising to ₹ 28,106.07 lakhs, operating EBITDA increasing to ₹ 3,175.59 lakhs, and PAT growing to ₹ 2,228.63 lakhs.
